孤立性胫动脉腔内治疗早期失败的影响
本研究回顾性分析了1779例因慢性肢体威胁性缺血接受孤立性胫动脉腔内治疗的患者,其中16%在30天内出现早期失败。早期失败与30天大截肢和主要肢体不良事件增加相关,并导致长期临床疗效和无截肢生存率显著降低。糖尿病和终末期肾病是早期失败的独立临床预测因素,病变钙化、参考血管直径<3 mm、病变长度>300 mm和踝下流出道差是独立解剖预测因素。
要点
- 早期失败(≤30天)发生率为16%,与30天大截肢和主要肢体不良事件增加相关。
- 糖尿病和终末期肾病是早期失败的独立临床预测因素。
- 病变钙化、参考血管直径<3 mm、病变长度>300 mm和踝下流出道差是早期失败的独立解剖预测因素。
核心结论
- 早期失败显著增加30天大截肢和30天主要肢体不良事件,并与长期患者导向结局差相关。
研究设计与样本
- 回顾性查询2007年至2017年下肢腔内治疗数据库,纳入1779例慢性肢体威胁性缺血(Rutherford 4、5、6级)患者,共2898条血管,排除术中技术失败,按患者进行意向性分析。
主要发现
- 284例(16%)手术为早期失败,其中124例(44%)在24小时内失败,160例(56%)在30天内失败。
- 失败模式为血流动力学失败(47%)和慢性肢体威胁性缺血进展(53%)。
关键数值与推荐
- 早期失败定义为术后30天内失败。
- 早期失败后 bypass 在静脉充足、靶血管≥3 mm且踝下流出道良好时成功。
- Rutherford 5级和6级疾病症状进展与 major amputation 相关。
临床怎么用
- 对于孤立性胫动脉腔内治疗,应评估糖尿病、终末期肾病等临床因素及病变钙化、参考血管直径<3 mm、病变长度>300 mm、踝下流出道差等解剖因素以预测早期失败风险。
- 早期失败后,若静脉充足、靶血管≥3 mm且踝下流出道良好,可考虑 bypass。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular tibial interventions for chronic limb-threatening ischemia are frequent, but the implications of early failure (≤30 days) of an isolated tibial intervention are still unclear. The aim of this study was to examine the patient-centered outcomes after early failure of isolated tibial artery intervention. METHODS: A database of patients undergoing lower extremity endovascular interventions between 2007 and 2017 was retrospectively queried. Patients with chronic limb-threatening ischemia (Rutherford classes 4, 5, and 6) were selected, and failures within 30 days were identified. Lack of technical success at the time of the procedure was an exclusion. Intention-to-treat analysis by patient was performed. Patient-oriented outcomes of clinical efficacy (absence of recurrent symptoms, maintenance of ambulation, and absence of major amputation), amputation-free survival (survival without major amputation), and freedom from major adverse limb events (MALEs; above-ankle amputation of the index limb or major reintervention [new bypass graft, jump or interposition graft revision]) were evaluated. RESULTS: There were 1779 patients (58% male; average age, 65 years; 2898 vessels) who underwent tibial intervention for chronic limb-threatening ischemia; 284 procedures (16%) were early failures. In the early failure group, 124 cases (44%) were considered immediate (<24 hours), and 160 cases (56%) failed within the first 30 days after intervention. The two modes of failure were hemodynamic failure (47%) and progression of chronic limb-threatening ischemia (53%). Bypass after early failure was successful in patients with adequate vein, target vessel of ≥3 mm, and good inframalleolar runoff. Progression of symptoms was associated with major amputation in patients with Rutherford class 5 and class 6 disease. Presentation with diabetes and end-stage renal disease were identified as independent clinical predictors for early failure. Lesion calcification, reference vessel diameter <3 mm, lesion length >300 mm, and poor inframalleolar runoff were identified as independent anatomic predictors for early failure and increased MALEs. Early failure was predictive of poor long-term clinical efficacy (11% ± 9% vs 39% ± 8% at 5 years, mean ± standard error of the mean, early vs no early failure; P = .01) and amputation-free survival (16% ± 9% vs 47% ± 9% at 5 years, mean ± standard error of the mean, early vs no early failure; P = .02). CONCLUSIONS: Both clinical and anatomic factors can predict early failure of endovascular therapy for isolated tibial disease. Early failure significantly increases 30-day major amputation and 30-day MALEs and is associated with poor long-term patient-centered outcomes.
引用
- Cheun TJ, Jayakumar L, Ferrer L, et al. Implications of early failure of isolated endovascular tibial interventions. J Vasc Surg. 2020. PMID: 32035771. doi:10.1016/j.jvs.2019.11.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。